India revokes GSK’s cancer drug patent
Mumbai: India has revoked a patent granted to GlaxoSmithKline for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that
HCU team stabilises cancer drug
In a major research that would benefit brain cancer patients living in tropical regions including India, a team from the University of Hyderabad has developed a method to increase the shelf life and e
Sun wins patent case against Eli Lily over cancer drug
New Delhi, July 29: Sun Pharma today claimed victory over Eli Lily and Co in a patent litigation over Gemzar, used in cancer treatment, with a US federal court ruling in its favour.
Eli Lily had cont